Untranslated Source: Ukraine Government

Translation begins:

Ukraine will receive an additional 320 thousand hydroxychloroquine tablets for the treatment of COVID-19 patients
April 9, 2020

The Ministry of Health will receive humanitarian aid, namely medicines with the active substance Hydroxychloroquine, included in the national treatment protocol COVID-19. Sanofi and Sandoz will deliver 320,000 tablets of this medicine to Ukraine, which is designed to treat over 22,000 patients.

The Minister of Health of Ukraine Maxim Stepanov has informed about it.

“The Ministry of Health is doing its best to combat the coronavirus as effectively as possible. Therefore, we have asked manufacturers to provide us with humanitarian assistance. This amount will be enough to treat over 22,000 patients with COVID-19, ”

Minister of Health Maxim Stepanov.

It should be noted that Plaquenil medication of Sanofi company (with active ingredient Hydroxychloroquine) is already distributed between the structural units for health care of the regional state administrations and Kiev with the subsequent admission to the first-wave healthcare institutions for receiving patients coronavirus infection. Delivery and distribution of Sandoz Hydroxychloroquine is expected early next week.

“This drug is prescribed in our protocol for the treatment of patients with COVID-19 and is used for severe patients only in hospital settings, as well as under the close supervision of doctors and with the written consent of patients. It will be free of charge for those patients who really need it for medical reasons, ”

Minister of Health Maxim Stepanov.

Recall that drugs with the active substance Hydroxychloroquine are used to treat patients with COVID-19 in the United States, Japan, Germany and other Western countries with advanced medicine.

See the official source here: https://moz.gov.ua/article/news/ukraina-otrimae-dodatkovi-320-tisjach-tabletok-gidroksihlorohinu-dlja-likuvannja-hvorih-na-covid-19

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »

Another New York State Supreme Court Justice Ivermectin Order Helping 81-Year-Old Farmer

Ivermectin, a medicine for parasites, has been around for four decades. While not authorized for use against COVID-19, dozens of studies show materially positive results. At well-established human dosage levels, the drug is safe: hundreds of millions of people are treated with it every year mostly in the tropics for various parasite-borne diseases, such as River Blindness in Nigeria.

Read More »

The Chloroquine Wars Part XIII -A Clockwork Orange Man

Immediately following HCQ’s Trump moment, the media went on an all-out blitz to associate the topic of HCQ with a sense of fear. Fear of Trump, fear of death, fear of incompetence, fear of opposing scientific authorities, fear of using medicine needed by somebody else, and fear of the unknown. And the campaign of fear didn’t stop there.

Read More »